# EDGAR Filing Document

**Accession Number:** 0001563665
**File Stem:** 0001437749-26-021480
**Filing Date:** 2026-6
**Character Count:** 7141
**Document Hash:** 6fc73c6486b9de7efc0664d20e38a29c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-021480.hdr.sgml**: 20260624

**ACCESSION NUMBER**: 0001437749-26-021480

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260618

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260624

**DATE AS OF CHANGE**: 20260623

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Harvard Apparatus Regenerative Technology, Inc.
- **CENTRAL INDEX KEY:** 0001563665
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 455210462
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35853
- **FILM NUMBER:** 261112692

**BUSINESS ADDRESS:**
- **STREET 1:** 84 OCTOBER HILL ROAD
- **STREET 2:** SUITE 11
- **CITY:** HOLLISTON
- **STATE:** MA
- **ZIP:** 01746
- **BUSINESS PHONE:** (774) 233-7300

**MAIL ADDRESS:**
- **STREET 1:** 84 OCTOBER HILL ROAD
- **STREET 2:** SUITE 11
- **CITY:** HOLLISTON
- **STATE:** MA
- **ZIP:** 01746

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Biostage, Inc.
- **DATE OF NAME CHANGE:** 20160331

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Harvard Apparatus Regenerative Technology, Inc.
- **DATE OF NAME CHANGE:** 20121204

?xml version='1.0' encoding='ASCII'? hrgn20260623_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): June 18, 2026

**HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-35853** | **45-5210462** |
| (State or other jurisdiction<br>of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

---

| | |
|:---|:---|
| **84 October Hill Road, Suite 11, Holliston, MA** | **01746** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(774) 233-7300**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07** | **Submission of Matters to a Vote of Security Holders.** |

---

On June 18, 2026, Harvard Apparatus Regenerative Technology, Inc., or the Company, held its Annual Meeting of Stockholders, or the Annual Meeting. At the Annual Meeting, the Company's stockholders voted on the following proposals: (i) the election of three Director Nominees as Class I Directors, each nominated by the Board of Directors of the Company for a one-year term, such term to continue until the annual meeting of stockholders in 2027 and until such Director's successor is duly elected and qualified or until their earlier resignation or removal, (ii) the ratification of the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, and (iii) the non-binding approval of the compensation of the Company's named executive officers. The voting results for the matters submitted to a stockholder vote at the Annual Meeting are reported below.

***Proposal 1 - Election of Directors***

On such election of directors proposal, each of Junli (Jerry) He, James Shmerling, and Mao Zhang were elected as Class I Directors, each for a one-year term, such term to continue until the annual meeting of stockholders in 2027 and until such Director's successor is duly elected and qualified or until their earlier resignation or removal. Due to the plurality election, votes could only be cast in favor of or withheld from the nominee and thus votes against were not applicable. The results of the election were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Votes For** | **Votes Withheld** | **Broker Non-Votes** |
| Junli (Jerry) He | 12,802,162 | 859,270 | 1,274,478 |
| James Shmerling | 10,725,274 | 2,936,158 | 1,274,478 |
| Mao Zhang | 12,804,230 | 857,202 | 1,274,478 |

---

***Proposal 2*** –***Ratification of the appointment of CBIZ CPAs P.C. as the Company***'***s** **independent registered public accounting firm for the fiscal year ending December 31, 2026***

The ratification of the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm was approved as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Against** | **Votes Abstained** | **Votes Abstained** | **Broker Non-Votes** | **Broker Non-Votes** |
|  | 14,077,329 |  | 5,417 |  | 853,164 |  | 0 |

---

***Proposal 3*** –***Approval, by Non-Binding Advisory Vote, of the Compensation of the Company***'***s** **Named Executive Officers***

The compensation of the Company's named executive officers was approved, by a non-binding advisory vote, as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Against** | **Votes Abstained** | **Votes Abstained** | **Broker Non-Votes** | **Broker Non-Votes** |
|  | 12,467,264 |  | 39,284 |  | 1,154,884 |  | 1,274,478 |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | **HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC.**&NBSP; |
| <br>**June 24, 2026** | (Registrant)<br>**/s/ Junli He** |
| (Date) | Junli He |
|  | *Chief Executive Officer* |

---